Pharmaceutical firm Abbott Laboratories said Tuesday that it is
licensing a catheter technology from health care products maker
Johnson & Johnson.
Abbott said its deal is depends on J&J completing its acquisition of
Guidant Corp. J&J announced separately Tuesday that it had
renegotiated the deal with the troubled pacemaker manufacturer for a
lower price.
Catheters are the flexible tubes used in a range of surgeries,
particularly heart operations. Abbott said the license covers certain
technology for developing and commercializing "rapid exchange"
delivery systems and related products such as drug-covered stents.
Abbott did not provide financial details of the deal.
Shares of Abbott Laboratories rose 98 cents, or 2.4 percent, to $41.50.
www.forbes.com
No comments:
Post a Comment